WebBy analyzing the IC50 values of the 54 SCLC cell lines shown in Figure 1B, we found that there are 35 cell lines that are sensitive to etoposide, accounting for 64.8% of the total, and their median and mean IC50 values were 2.06 μM (range: 0.242–15.2 μM) and 4.02±4.07 μM, respectively. In total, 19 strains were resistant to etoposide ... WebMay 18, 2011 · Irinotecan will be given intravenously over 1 hour on days 1-5 of each course, one hour following the administration of temozolomide. In the absence of any contraindication (ie known allergies), treatment with oral cefixime 8 mg/kg once daily (maximum daily dose 400 mg) is recommended and will be started 2 days before …
Irinotecan (CPT-11) HCl Trihydrate ≥99%(HPLC) Selleck …
WebFeb 23, 2024 · Our results show that irinotecan and CHEK1 inhibition have synergistic effects in microsatellite-stable or KRAS–TP53 double-mutant colon cancer cells, leading to apoptosis and suppression of ... WebThe IC50 of irinotecan in HT29, NMG64/84, COLO-357, MIA PaCa-2 and PANC-1 cells at 30 min were 200, 160, 100, 400 and 150 microg/ml, respectively, in the HTCA. All isolated … hydranal composite 5k sds
Establishment and Characterization of Human Colon-Cancer
WebIrinotecan is a prodrug, and hydrolysis of irinotecan by the carboxyesterase-2 enzyme in many normal tissues is responsible for activation of irinotecan to SN-38, a potent … WebDec 21, 2024 · SN 38 is anctive metabolite of CPT-11 that inhibits DNA topoisomerase I (IC50 values are 0.74 and 1.9 μM in P388 and Ehrlich cells respectively). During hydrolysis, SN 38 is formed when the carboxylesterases metabolize irinotecan through glucuronidation by UDP glucuronosyl transferase 1A1. Compared to irinotecan, SN 38 is a more potent ... WebIrinotecan (CPT-11), a prodrug for treating metastatic colorectal cancer, is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively … massachusetts rehab commission